Coexisting Diseases & Surgery vs Pedi Crisis 2.0 Uso e estatísticas

A comprehensive medical disease app that contains the following: 1) Gives the description, etiology, onset, diagnosis, pathophysiology, treatment, and prognosis of common and rare diseases. 2) Provides specific information how to manage the surgical patient’s coexisting disease(s) perioperatively, and what the disease related concerns are. One-time purchase with free updates. This app is equivalent to a 4,000 page book and will always be expanded with frequent updates. Categories: Brain/Neuro Cardiac Hematologic Disorders GI System Endocrine System Liver and Biliary Tract Pediatrics Renal Disease Pulmonary Congenital Heart Disease (coming soon)
  • Apple App Store
  • Pagos
  • Médico

Ranking da Loja

- -

The Society for Pediatric Anesthesia (SPA) presents Pedi Crisis 2.0! This app contains peer-reviewed algorithms for treating 26 pediatric crisis situations. As an interactive version of the SPA critical event checklists, crucial details for these 26 pediatric critical events are now just a ‘tap’ away on your pocket device! Quick reference drug dosage summaries are available for each emergency. Enter the patient’s weight to automatically calculate patient-specific dosages.
  • Apple App Store
  • Gratuitos
  • Médico

Ranking da Loja

- -

Coexisting Diseases & Surgery versus Pedi Crisis 2.0 comparação de classificação

Compare a tendência de classificação de Coexisting Diseases & Surgery nos últimos 28 dias versus Pedi Crisis 2.0

Coexisting Diseases & SurgeryCoexisting Diseases & Surgery#81

Classificação

Comparação da classificação de Coexisting Diseases & Surgery vs. Pedi Crisis 2.0 por país

Compare a tendência de classificação de Coexisting Diseases & Surgery nos últimos 28 dias versus Pedi Crisis 2.0

Todas as categorias

Nenhum dado disponível

Médico

Aplicativo
País principal
Classificação
#81
#74

Faça comparações com qualquer site com o nosso teste grátis

Comece agora
Coexisting Diseases & Surgery VS.
Pedi Crisis 2.0

11ezembro d, 2024